Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

HealthEquity Temettü

Temettü kriter kontrolleri 0/6

HealthEquity şirketinin temettü ödeme geçmişi bulunmamaktadır.

Anahtar bilgiler

n/a

Temettü verimi

n/a

Ödeme oranı

Sektör ortalama getirisi	1.6%
Bir sonraki temettü ödeme tarihi	n/a
Eski temettü tarihi	n/a
Hisse başına temettü	n/a
Hisse başına kazanç	US$1.21
Temettü verim tahmini	0%

Son temettü güncellemeleri

Güncelleme yok

Recent updates

We Think Some Shareholders May Hesitate To Increase HealthEquity, Inc.'s (NASDAQ:HQY) CEO Compensation

Jun 21

Earnings Beat: HealthEquity, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Jun 07

HealthEquity: A Trading Vehicle Performing As Expected, Strong Growth Hard To Ignore

Jun 04

HealthEquity: Strong Growth And Healthy Cash Flows Changed My Mind

May 29

Are Investors Undervaluing HealthEquity, Inc. (NASDAQ:HQY) By 48%?

May 03

Market Participants Recognise HealthEquity, Inc.'s (NASDAQ:HQY) Revenues

Apr 11

HealthEquity: Multiple Compression Has Finally Made It A Buy

Mar 21

Investors Appear Satisfied With HealthEquity, Inc.'s (NASDAQ:HQY) Prospects

Dec 28

Is HealthEquity (NASDAQ:HQY) A Risky Investment?

Nov 17

HealthEquity, Inc.'s (NASDAQ:HQY) Intrinsic Value Is Potentially 51% Above Its Share Price

Oct 26

Does HealthEquity (NASDAQ:HQY) Have A Healthy Balance Sheet?

Jul 27

HealthEquity, Inc. (NASDAQ:HQY) Shares Could Be 37% Below Their Intrinsic Value Estimate

Jul 07

Does HealthEquity (NASDAQ:HQY) Have A Healthy Balance Sheet?

Apr 18

Estimating The Intrinsic Value Of HealthEquity, Inc. (NASDAQ:HQY)

Mar 14

Is HealthEquity (NASDAQ:HQY) Using Too Much Debt?

Dec 24

Is Now An Opportune Moment To Examine HealthEquity, Inc. (NASDAQ:HQY)?

Dec 02

Is HealthEquity, Inc. (NASDAQ:HQY) Expensive For A Reason? A Look At Its Intrinsic Value

Nov 11

These 4 Measures Indicate That HealthEquity (NASDAQ:HQY) Is Using Debt Extensively

Sep 08

HealthEquity Non-GAAP EPS of $0.33 in-line, revenue of $206.1M beats by $2.22M

Sep 06

HealthEquity: Asymmetry In Valuation Continues To Widen

Aug 25

HealthEquity COO steps down, CEO to assume his responsibilities

Aug 02

Is Now An Opportune Moment To Examine HealthEquity, Inc. (NASDAQ:HQY)?

Jul 27

Calculating The Intrinsic Value Of HealthEquity, Inc. (NASDAQ:HQY)

Jul 06

These 4 Measures Indicate That HealthEquity (NASDAQ:HQY) Is Using Debt Extensively

May 24

Is Now An Opportune Moment To Examine HealthEquity, Inc. (NASDAQ:HQY)?

Apr 12

An Intrinsic Calculation For HealthEquity, Inc. (NASDAQ:HQY) Suggests It's 29% Undervalued

Mar 16

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: HQY şirketinin hisse başına düşen temettülerinin geçmişte istikrarlı olup olmadığını belirlemek için yeterli veri yok.

Büyüyen Temettü: HQY şirketinin temettü ödemelerinin artıp artmadığını belirlemek için yeterli veri yok.

Piyasaya Karşı Temettü Getirisi

HealthEquity Piyasaya Karşı Temettü Getirisi

HQY temettü verimi piyasa ile karşılaştırıldığında nasıldır?
Segment	Temettü Verimi
Şirket (HQY)	n/a
Pazarın Alt %25'i (US)	1.4%
Pazarın En İyi %25'i (US)	4.3%
Sektör Ortalaması (Healthcare)	1.6%
Analist tahmini (HQY) (3 yıla kadar)	0%

Önemli Temettü: HQY şirketinin temettü getirisi, şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, temettü ödeyenlerin en alttaki %25'lik dilimine göre değerlendirilemiyor.

Yüksek Temettü: Şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, HQY şirketinin temettü getirisi, temettü ödeyenlerin en üst %25'ine göre değerlendirilemiyor.

Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: HQY şirketinin temettü ödemelerinin kazançlarla karşılanıp karşılanmadığını belirlemek için ödeme oranını hesaplamak üzere yeterli veri yok.

Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: HQY herhangi bir ödeme bildirmediğinden temettülerin sürdürülebilirliği hesaplanamıyor.

HealthEquity Temettü

Temettü kriter kontrolleri 0/6

Anahtar bilgiler

Son temettü güncellemeleri

Recent updates

Executive VP & CTO recently sold US$947k worth of stock

Independent Director notifies of intention to sell stock

HealthEquity, Inc. (NasdaqGS:HQY) announces an Equity Buyback for $300 million worth of its shares.

Getting In Cheap On HealthEquity, Inc. (NASDAQ:HQY) Might Be Difficult

HealthEquity: Compelling Catalysts, Fairly Valued, Reiterate Buy

HealthEquity, Inc. to Report Q2, 2025 Results on Sep 03, 2024

Founder & Vice Chairman exercised options and sold US$2.3m worth of stock

Is HealthEquity (NASDAQ:HQY) Using Too Much Debt?

President notifies of intention to sell stock

We Think Some Shareholders May Hesitate To Increase HealthEquity, Inc.'s (NASDAQ:HQY) CEO Compensation

Consensus EPS estimates increase by 15%

Founder & Vice Chairman notifies of intention to sell stock

Earnings Beat: HealthEquity, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

HealthEquity, Inc. Provides Earnings Guidance for the Fiscal Year Ending January 31, 2025

First quarter 2025 earnings: EPS and revenues exceed analyst expectations

HealthEquity: A Trading Vehicle Performing As Expected, Strong Growth Hard To Ignore

HealthEquity: Strong Growth And Healthy Cash Flows Changed My Mind

HealthEquity, Inc. to Report Q1, 2025 Results on Jun 03, 2024

Are Investors Undervaluing HealthEquity, Inc. (NASDAQ:HQY) By 48%?

HealthEquity, Inc., Annual General Meeting, Jun 27, 2024

Market Participants Recognise HealthEquity, Inc.'s (NASDAQ:HQY) Revenues

President notifies of intention to sell stock

HealthEquity: Multiple Compression Has Finally Made It A Buy

Full year 2024 earnings: EPS exceeds analyst expectations

HealthEquity, Inc. to Report Q4, 2024 Results on Mar 19, 2024

Consensus EPS estimates increase by 19%

HealthEquity, Inc. Provides Earnings Guidance for the Fiscal Year Ended January 31, 2024 and Fiscal Year Ending January 31, 2025

Investors Appear Satisfied With HealthEquity, Inc.'s (NASDAQ:HQY) Prospects

Consensus EPS estimates increase by 39%

Founder & Vice Chairman notifies of intention to sell stock

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

HealthEquity, Inc. Provides Earnings Guidance for the Fiscal Year Ending January 31, 2024 and 2025

Is HealthEquity (NASDAQ:HQY) A Risky Investment?

HealthEquity, Inc. to Report Q3, 2024 Results on Dec 05, 2023

HealthEquity, Inc.'s (NASDAQ:HQY) Intrinsic Value Is Potentially 51% Above Its Share Price

President notifies of intention to sell stock

HealthEquity, Inc. (NasdaqGS:HQY) entered into a definitive agreement to acquire BenefitWallet’s Health Savings Account (HSA) portfolio from Conduent Business Services, LLC for $425 million.

HealthEquity, Inc. Provides Earnings Guidance for the Fiscal Year Ending January 31, 2024

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

HealthEquity, Inc. to Report Q2, 2024 Results on Sep 05, 2023

HealthEquity, Inc. Announces the Termination of the Employment of Larry Trittschuh, Executive Vice President and Chief Security Officer

Does HealthEquity (NASDAQ:HQY) Have A Healthy Balance Sheet?

HealthEquity, Inc. (NASDAQ:HQY) Shares Could Be 37% Below Their Intrinsic Value Estimate

President notifies of intention to sell stock

Executive VP & CTO recently sold US$653k worth of stock

HealthEquity, Inc. Announces Change of CFO

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

HealthEquity, Inc. Provides Earnings Guidance for the Year Ending January 31, 2024

HealthEquity, Inc. to Report Q1, 2024 Results on Jun 05, 2023

Does HealthEquity (NASDAQ:HQY) Have A Healthy Balance Sheet?

Full year 2023 earnings: EPS exceeds analyst expectations

Estimating The Intrinsic Value Of HealthEquity, Inc. (NASDAQ:HQY)

Is HealthEquity (NASDAQ:HQY) Using Too Much Debt?

Independent Director recently sold US$325k worth of stock

HealthEquity, Inc. Provides Earnings Guidance for the Fiscal Year Ending January 31, 2023 and January 31, 2024

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Is Now An Opportune Moment To Examine HealthEquity, Inc. (NASDAQ:HQY)?

HealthEquity, Inc. to Report Q3, 2023 Results on Dec 06, 2022

Is HealthEquity, Inc. (NASDAQ:HQY) Expensive For A Reason? A Look At Its Intrinsic Value

Executive VP notifies of intention to sell stock

Executive VP & Chief Security Officer exercised options and sold US$67k worth of stock

Independent Director recently sold US$300k worth of stock

Independent Director recently sold US$1.8m worth of stock

These 4 Measures Indicate That HealthEquity (NASDAQ:HQY) Is Using Debt Extensively

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

HealthEquity, Inc. Provides Earnings Guidance for the Fiscal Year Ending January 31, 2023

HealthEquity Non-GAAP EPS of $0.33 in-line, revenue of $206.1M beats by $2.22M

Healthequity, Inc. Elects Paul M. Black to Board of Directors and to Audit and Risk Committee and Talent, Compensation and Culture Committee

HealthEquity: Asymmetry In Valuation Continues To Widen

HealthEquity, Inc. to Report Q2, 2023 Results on Sep 06, 2022

HealthEquity, Inc. Announces Executive Changes

HealthEquity COO steps down, CEO to assume his responsibilities

Now 21% undervalued after recent price drop

Is Now An Opportune Moment To Examine HealthEquity, Inc. (NASDAQ:HQY)?

Now 21% undervalued after recent price drop